Business UpdateMay 26, 2026, 08:07 AM
Moleculin Biotech Posts May 2026 Investor Presentation
AI Summary
Moleculin Biotech, Inc. announced the release of its updated corporate presentation. The presentation, dated May 2026, is now available on the company's website and has been furnished to the SEC as Exhibit 99.1 to a Form 8-K. This filing serves to make the presentation publicly accessible under Regulation FD.
Key Highlights
- Moleculin Biotech released an updated corporate presentation.
- The presentation is dated May 2026.
- It has been posted on the company's website.
- The presentation was filed as Exhibit 99.1 to a Form 8-K.
- The information is furnished under Regulation FD Disclosure.
Price Impact
More from MBRX